Tyvin Rich, Chief Medical Officer at Shuttle Pharmaceuticals Holdings, Inc. (SHPH), sold 1,414 shares at $1.61 ($2K) on 2022-12-29, disclosed to the SEC on 2023-01-03.
Open-market sale of $2k SHPH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.